Midatech makes board change
This article was originally published in Scrip
Midatech Pharma has announced that Jeff Brown is stepping down from its board of directors, following the company's IPO, to pursue other business interests. The change is effective from 30 April 2015. Midatech, headquartered in Oxford, UK, has a pipeline of product candidates in clinical and preclinical development in the key therapeutic areas of diabetes, cancer and neurological/ophthalmological diseases. The company floated on the AIM Market of the London Stock Exchange in December 2014.